EDGAR Filing Documents for 0001558370-23-003906

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001558370-23-003906

Filing Date

2023-03-15

Accepted

2023-03-15 16:46:42

Documents

104

Period of Report

2022-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	ptgx-20221231x10k.htm iXBRL	10-K	2708192
2	EX-4.3	ptgx-20221231xex4d3.htm	EX-4.3	19681
3	EX-10.25	ptgx-20221231xex10d25.htm	EX-10.25	37923
4	EX-10.26	ptgx-20221231xex10d26.htm	EX-10.26	43294
5	EX-21.1	ptgx-20221231xex21d1.htm	EX-21.1	3484
6	EX-23.1	ptgx-20221231xex23d1.htm	EX-23.1	3814
7	EX-31.1	ptgx-20221231xex31d1.htm	EX-31.1	11390
8	EX-31.2	ptgx-20221231xex31d2.htm	EX-31.2	11618
9	EX-32.1	ptgx-20221231xex32d1.htm	EX-32.1	10837
10	GRAPHIC	ptgx-20221231x10k006.jpg	GRAPHIC	94491
11	GRAPHIC	ptgx-20221231x10k007.jpg	GRAPHIC	66327
12	GRAPHIC	ptgx-20221231x10k008.jpg	GRAPHIC	80767
13	GRAPHIC	ptgx-20221231x10k009.jpg	GRAPHIC	66376
14	GRAPHIC	ptgx-20221231xex10d25001.jpg	GRAPHIC	10776
	Complete submission text file	0001558370-23-003906.txt		11919506

Data Files

Seq	Description	Document	Type	Size
15	EX-101.SCH	ptgx-20221231.xsd	EX-101.SCH	76495
16	EX-101.CAL	ptgx-20221231_cal.xml	EX-101.CAL	73572
17	EX-101.DEF	ptgx-20221231_def.xml	EX-101.DEF	304022
18	EX-101.LAB	ptgx-20221231_lab.xml	EX-101.LAB	580145
19	EX-101.PRE	ptgx-20221231_pre.xml	EX-101.PRE	516128
98	EXTRACTED XBRL INSTANCE DOCUMENT	ptgx-20221231x10k_htm.xml	XML	1988079

Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160

Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170

Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)